Jozef Stec

619 total citations
18 papers, 478 citations indexed

About

Jozef Stec is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Jozef Stec has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Organic Chemistry. Recurrent topics in Jozef Stec's work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (6 papers) and Toxoplasma gondii Research Studies (4 papers). Jozef Stec is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (6 papers) and Toxoplasma gondii Research Studies (4 papers). Jozef Stec collaborates with scholars based in United States, France and Italy. Jozef Stec's co-authors include Alan P. Kozikowski, William R. Bishai, Shichun Lun, Oluseye K. Onajole, Haidan Guo, Giulio Vistoli, Marco Pieroni, Hendra Gunosewoyo, Nicole C. Ammerman and Suresh K. Tipparaju and has published in prestigious journals such as Biochemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jozef Stec

18 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jozef Stec United States 10 261 213 203 203 36 18 478
Julie V. Early United States 14 289 1.1× 173 0.8× 210 1.0× 217 1.1× 39 1.1× 27 534
Lisa K. Woolhiser United States 15 363 1.4× 127 0.6× 255 1.3× 230 1.1× 93 2.6× 18 634
Alfonso Mendoza-Losana Spain 12 271 1.0× 75 0.4× 243 1.2× 189 0.9× 37 1.0× 18 478
Suresh B. Lakshminarayana Singapore 12 333 1.3× 110 0.5× 196 1.0× 216 1.1× 55 1.5× 15 573
Agnieszka Napiórkowska Poland 15 229 0.9× 309 1.5× 221 1.1× 167 0.8× 35 1.0× 30 640
Jérémie Piton Switzerland 17 507 1.9× 125 0.6× 551 2.7× 294 1.4× 53 1.5× 33 913
Ali Nasser Eddine Germany 11 247 0.9× 50 0.2× 206 1.0× 174 0.9× 15 0.4× 15 488
Mary Ann Powles United States 10 137 0.5× 81 0.4× 72 0.4× 148 0.7× 29 0.8× 11 411
Hataichanok Scherman United States 9 148 0.6× 64 0.3× 291 1.4× 120 0.6× 13 0.4× 9 442
Robin E. B. Lee United States 7 280 1.1× 154 0.7× 208 1.0× 169 0.8× 12 0.3× 8 533

Countries citing papers authored by Jozef Stec

Since Specialization
Citations

This map shows the geographic impact of Jozef Stec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jozef Stec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jozef Stec more than expected).

Fields of papers citing papers by Jozef Stec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jozef Stec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jozef Stec. The network helps show where Jozef Stec may publish in the future.

Co-authorship network of co-authors of Jozef Stec

This figure shows the co-authorship network connecting the top 25 collaborators of Jozef Stec. A scholar is included among the top collaborators of Jozef Stec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jozef Stec. Jozef Stec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stec, Jozef & William H. Witola. (2023). Alternatives to piperidine in Knoevenagel condensation of 2-cyanoacetamide with benzaldehydes. Results in Chemistry. 6. 101212–101212. 3 indexed citations
2.
Khan, Shahbaz M., et al.. (2022). Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum. International Journal for Parasitology Drugs and Drug Resistance. 19. 6–20. 4 indexed citations
3.
Li, Kun, et al.. (2020). Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum. International Journal for Parasitology Drugs and Drug Resistance. 14. 80–90. 5 indexed citations
4.
Stec, Jozef, et al.. (2020). Analysis of Student Perceptions of Just-In-Time Teaching Pedagogy in PharmD Microbiology and Immunology Courses. Frontiers in Immunology. 11. 351–351. 8 indexed citations
5.
Daher, Wassim, Françoise Roquet‐Banères, Matt D. Johansen, et al.. (2020). Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 64(5). 11 indexed citations
6.
Cramer, Sarah D., et al.. (2019). Modulation of the Endocannabinoid System via Inhibition of Fatty Acid Amide Hydrolase (FAAH) by Novel Urea and Carbamate Derivatives. ChemistrySelect. 4(39). 11609–11614. 2 indexed citations
7.
Cao, Ruoqiong, Hicret Islamoglu, Garrett Teskey, et al.. (2019). The preclinical candidate indole-2-carboxamide improves immune responses to Mycobacterium tuberculosis infection in healthy subjects and individuals with type 2 diabetes. International Microbiology. 23(2). 161–170. 7 indexed citations
8.
Lun, Shichun, Rokeya Tasneen, Jozef Stec, et al.. (2019). Advancing the Therapeutic Potential of Indoleamides for Tuberculosis. Antimicrobial Agents and Chemotherapy. 63(7). 14 indexed citations
9.
Viljoen, Albertus, Jean‐Louis Herrmann, Oluseye K. Onajole, et al.. (2017). Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport. Frontiers in Cellular and Infection Microbiology. 7. 388–388. 17 indexed citations
11.
Kozikowski, Alan P., Oluseye K. Onajole, Jozef Stec, et al.. (2017). Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections. Journal of Medicinal Chemistry. 60(13). 5876–5888. 56 indexed citations
12.
Stec, Jozef, Oluseye K. Onajole, Shichun Lun, et al.. (2016). Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection. Journal of Medicinal Chemistry. 59(13). 6232–6247. 137 indexed citations
13.
Stec, Jozef & Ehab A. Abourashed. (2015). Recently Disclosed Chemical Entities As Potential Candidates for Management of Tuberculosis. Pharmaceutical Patent Analyst. 4(4). 317–347. 3 indexed citations
15.
Stec, Jozef, Stephen P. Muench, Ying Zhou, et al.. (2013). Modification of Triclosan Scaffold in Search of Improved Inhibitors for Enoyl‐Acyl Carrier Protein (ACP) Reductase in Toxoplasma gondii. ChemMedChem. 8(7). 1138–1160. 18 indexed citations
16.
Muench, Stephen P., Martin J. McPhillie, Arne Schön, et al.. (2013). Discrimination of Potent Inhibitors ofToxoplasma gondiiEnoyl-Acyl Carrier Protein Reductase by a Thermal Shift Assay. Biochemistry. 52(51). 9155–9166. 9 indexed citations
17.
Onajole, Oluseye K., Marco Pieroni, Suresh K. Tipparaju, et al.. (2013). Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains. Journal of Medicinal Chemistry. 56(10). 4093–4103. 109 indexed citations
18.
Stec, Jozef, Qingqing Huang, Marco Pieroni, et al.. (2012). Synthesis, Biological Evaluation, and Structure–Activity Relationships of N-Benzoyl-2-hydroxybenzamides as Agents Active against P. falciparum (K1 strain), Trypanosomes, and Leishmania. Journal of Medicinal Chemistry. 55(7). 3088–3100. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026